Trial
NCT00984217
Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Pittsburgh
Collaborators
Amgen
Condition
Adenoma, Pleomorphic
Intervention
Radiation
Why stopped
Decided not to pursue at UPCI
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-08